We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ALZN market cap is 6.19M. The company's latest EPS is USD -1.8311 and P/E is -0.62.
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.53M | -2.9M | -2.66M | -851k | -962k |
| Net Income | -3.53M | -2.91M | -2.66M | -852k | -974k |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.17M | -4.95M | -12.32M | -14.87M | -9.94M |
| Net Income | -3.17M | -5.05M | -12.36M | -14.88M | -9.95M |
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.63M | 984k | 783k | 631k | 1.67M |
| Total Liabilities | 2.74M | 3.67M | 4.57M | 3.23M | 2.88M |
| Total Equity | -113k | -2.68M | -4.26M | -2.59M | -1.21M |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.81M | 2.91M | 14.52M | 5.92M | 631k |
| Total Liabilities | 992k | 899k | 1.17M | 2.87M | 3.23M |
| Total Equity | 822k | 2.01M | 13.35M | 3.05M | -2.59M |
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.3M | -4.81M | -6.84M | -8.27M | -1.06M |
| Investing | -147k | -147k | -147k | -147k | -90k |
| Financing | N/A | 18k | 2.13M | 3.65M | 1.96M |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.15M | -2.71M | -6.61M | -8.92M | -8.27M |
| Investing | 105k | 101k | -106k | N/A | -147k |
| Financing | 2.29M | 4.45M | 18.85M | N/A | 3.65M |
| Market Cap | 6.19M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 16.47 |
| Price to Book Ratio | -2.39 |
| Dividend Yield | - |
| Shares Outstanding | 5.43M |
| Average Volume (1 week) | 48.01k |
| Average Volume (1 Month) | 70.47k |
| 52 Week Change | -87.47% |
| 52 Week High | 15.06 |
| 52 Week Low | 1.06 |
| Spread (Intraday) | 0.04 (3.39%) |
| Company Name | Alzamend Neuro Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.alzamend.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
